06.08.21

Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of Eyetelligence Clinical Decision Support Software

Source: Bausch + Lomb

Bausch + Lomb announced that its affiliate has entered into an agreement with Lochan LLC to develop the next-generation of Bausch + Lomb’s eyeTELLIGENCE clinical decision support software. Using the existing cloud-based infrastructure of eyeTELLIGENCE, this analytical software is being designed to allow surgeons to seamlessly integrate all aspects of the cataract, retinal and refractive surgery processes to maximize their overall practice efficiency. The companies expect to launch the initial phase of this next-generation software in 2022.

“A huge opportunity to streamline the surgical planning process still exists, and we are committed to developing and delivering digital solutions designed to improve integration and practice efficiency,” Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb, said in a company news release. “The launch of the eyeTELLIGENCE platform was Bausch + Lomb’s first step on this journey. We believe that the development collaboration with Lochan will allow us to greatly expand upon the platform’s capabilities and thus enhance the surgical planning process for doctors, staff and their patients.”

Ophthalmic surgical procedures require a sophisticated, multi-step process that involves patient diagnostics, clinical treatment planning, surgery planning, post-op analysis and more. Today, the transitions between each step require the manual transfer of data, which can be time consuming and lead to unintended human error. The next-generation eyeTELLIGENCE software platform is being designed to create opportunities to streamline this complex process, resulting in a more seamless connection from pre surgery assessment to treatment planning and execution to post surgery evaluation.

“As a practicing surgeon, I have experienced first-hand the disconnect that exists between the different phases of the surgical planning process and the lack of interconnectivity between technologies that we use,” said Mark Lobanoff, MD, director of refractive surgery, North Suburban Eye Specialists, Minneapolis, MN, and Founder, Lochan LLC. “Just as Bausch + Lomb introduced eyeTELLIGENCE to help address these challenges, I founded Lochan because I understood the benefits that digital integration could bring. That’s why I believe that together, we will be able to bring the capabilities of eyeTELLIGENCE to the next level—helping surgeons use data to make more informed and faster procedural and treatment decisions.”

In 2018, Bausch + Lomb launched the eyeTELLIGENCE cloud-based digital platform as a way to help surgeons work smarter and find new ways to use data to maximize their overall practice efficiency. Today, eyeTELLIGENCE, which is exclusively available on the Stellaris Elite vision enhancement system, is used by surgeons across the United States.

 

Related Content